Explore the Role of NLRP7 in the Regulation of Progestereone Induced Decidualization of Human Endometrial Stroma Cells
NCT04148638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 204
Last updated 2022-10-05
Summary
The investigators have found that NLRP7 was upregulated and nuclear translocated in an in vitro model of decidualization. Knock-down or overexpression of NLRP7 reduced or enhanced the expression of decidual marker IGFBP-1. NLRP7 was also found to promote progesterone receptor (PR) activity. So, the investigators hypothesized that NLRP7 may regulate progesterone-induced decidualization of human endometrial stromal cells. Part I is to explore how NLRP7 is induced during the decidualization. According to the luciferase activities of NLRP7 promoter luciferase reporter systems, the region from -100 to +37 or from -1200 to -100 had positive or negative regulatory elements, respectively, in the in vitro decidualization. Part II is to explore how NLRP7 contributes the decidualization of endometrial stromal cells. By immunoprecipitations of NLRP7 or PR, the investigators found NLRP7 might involve in the transcriptional complex of PR in the in vitro decidualization. The NLRP7 interacting protein in the co-immunoprecipitations the investigatorsre analyzed by LC/MS-MS. Part III is to explore the effects of NLRP7 mutations on in vitro decidualization and macrophage differentiation.
Comparing to RFP control, the investigators found wild-type NLRP7 enhanced but NLRP7 mutants reduced IGFBP-1 expression in the in vitro decidualization. In the M1 macrophage differentiation of THP-1, wild-type and mutant NLRP7 reduced IL-1β expression compared to the RFP control. Part IV is to explore a role of MPA in macrophage differentiation. MPA drives THP-1 cells a M2-like macrophage differentiation toward a phenotype of decidual macrophages, which promoted in vitro decidualization and trophoblastic invasion, but tolerated TLR ligands stimulations. In conclusion, NLRP7 contributes in vitro decidualization of endometrial stromal cells; NLRP7 mutation may impede in vitro decidualization; NLRP7 may suppress IL-1 expression in M1 macrophage differentiation; MPA drives M2 macrophage differentiation toward a phenotype of decidual macrophage.
Conditions
- Inflammatory Response
- Abortion, Habitual
Sponsors & Collaborators
-
National Cheng-Kung University Hospital
lead OTHER
Principal Investigators
-
Pao-Lin Kuo, MD · Department of Obstetrics and Gynecology, National Cheng Kung University Hospital
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-08-31
- Primary Completion
- 2018-07-31
- Completion
- 2018-07-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Maternal and Fetal Adrenocorticotropic Hormone (ACTH) and Leukemia Inhibitory Factor (LIF) and Gestational Age
NCT03231904 ·Status: UNKNOWN
-
Progesterone Levels and Pregnancy Results
NCT04400149 ·Status: UNKNOWN
-
Cyclin-dependent Kinase Inhibitor 2A (Placental Senescence Marker) on Labor-related Signals
NCT05864066 ·Status: UNKNOWN
-
Influence of Preconceptional Obesity on the Myometrial Cells Differentiation Toward a Contractyl Phenotype
NCT01762683 ·Status: COMPLETED ·Phase: NA
-
the Implications of Pathogenesis of Pre-Eclampsia
NCT00154934 ·Status: TERMINATED
-
Progesterone for First Trimester Vaginal Bleeding
NCT01501890 ·Status: WITHDRAWN ·Phase: NA
-
Role of L-citrulline in Prevention of Pregnancy Associated Hypertension
NCT04979793 ·Status: SUSPENDED ·Phase: PHASE1
-
Correlation Between LIF (Leukemia Inhibitory Factor ) Levels in Cord and Maternal Blood in Women Treated With Mg
NCT02507817 ·Status: UNKNOWN
-
Interleukin-10 Promoter-1082A/G Polymorphism and Idiopathic Recurrent Miscarriage Risk
NCT02633475 ·Status: UNKNOWN
-
Effect of Hydroxytyrosol on NLR, MLR, and SOD in Hypertensive Pregnant Women
NCT07074548 ·Status: COMPLETED ·Phase: NA
-
Fetal Growth and Placental Function in Pregnancies Complicated by Diabetes
NCT04801121 ·Status: UNKNOWN
-
Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss
NCT04558268 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Inflammatory Markers in Preeclampsia
NCT01385813 ·Status: COMPLETED
-
Study on Retroplacental Hematomas in Finistère
NCT04168606 ·Status: COMPLETED
-
Predictive BioMArkers of AlTERed NeurologicAL Trajectories Consequent to PrenataL InflammatorY Insults
NCT06852703 ·Status: RECRUITING
-
Study of Placental Function in Healthy and Pathological Pregnancies
NCT02321007 ·Status: RECRUITING
-
Unexplained Recurrent Pregnancy Loss: New Therapeutic Perspectives
NCT06867900 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
MR and Inflammation After Preeclampsia
NCT07345845 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Maternal-fetal Immune Responses to Fetal Surgery
NCT04484441 ·Status: COMPLETED
-
GROSS-HIST : Quantification of the Main Circulating Histones During Normal Pregnancy and Pregnancies With Placenta-mediated Complications
NCT04205383 ·Status: COMPLETED
-
The Placental Secretome as a Therapeutic Tool to Prevent Inflammation-induced Preterm Birth
NCT06891508 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Steroid Hormones, TH1/TH2 Cytokines and Reproductive Status
NCT00001376 ·Status: COMPLETED
-
Intravenous Immunoglobulin and Prednisolone for RPL After ART.
NCT04701034 ·Status: COMPLETED ·Phase: PHASE2
-
Possible Epigenetic Changes in Offspring of Women With Pregestational and Gestational Diabetes
NCT01255384 ·Status: UNKNOWN
-
COVID-19 on Placental Gene Expression and Pathology
NCT04585945 ·Status: COMPLETED